Global Medical REIT Inc. Financial Ratios
GMRE / Real Estate|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
1.3%
Profit Margin
4.8%
Net Income / Revenue
Asset Turnover
0.11
Revenue / Total Assets
Equity Multiplier
2.35
Total Assets / Equity
Composite: 1.3% (reported: 1.3%)
Profitability
Gross Margin
-
Operating Margin
-
EBITDA
$47.1M
EBITDA Margin
34.0%
Liquidity
Current Ratio
-
Quick Ratio
-
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.11
Inventory Turnover
-
Days Sales Outstanding
20 days
As of FY2024 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-5.0%
-1.3pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.